• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于替换距离探索新冠病毒的多样性

Exploring Diversity of COVID‑19 Based on Substitution Distance.

作者信息

Chen Yi-Hau, Wang Hsiuying

机构信息

Institute of Statistical Science, Academia Sinica, Nankang, Taipei, Taiwan.

Institute of Statistics, National Chiao Tung University, Hsinchu, Taiwan.

出版信息

Infect Drug Resist. 2020 Oct 29;13:3887-3894. doi: 10.2147/IDR.S277620. eCollection 2020.

DOI:10.2147/IDR.S277620
PMID:33149633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7605616/
Abstract

BACKGROUND

The number of COVID-19 infections worldwide has reached 10 million. COVID‑19 caused by SARS-CoV-2 is more contagious than SARS-CoV-1. There is a dispute about the origin of COVID-19. Study results showed that all SARS-CoV-2 sequences around the world share a common ancestor towards the end of 2019.

METHODS

Virus sequences from COVID-19 samples at the early time should be less diversifiable than those from samples at the later time because there might be more mutations when the virus evolutes over time. The diversity of virus nucleotide sequences can be measured by the nucleotide substitution distance. To explore the diversity of SARS-CoV-2, we use different nucleotide substitution models to calculate the distances of SARS-CoV-2 samples from 3 different areas, China, Europe, and the USA. Then, we use these distances to infer the origin of COVID-19.

RESULTS

It is known that COVID-19 originated in Wuhan China and then spread to Europe and the USA. By using different substitution models, the distances of SARS-CoV-2 samples from these areas are significantly different. By ANOVA testing, the p-value is less than 2.2e-16. The analyzed results in most substitution models show that China has the lowest diversity, followed by Europe and lastly by the USA. This outcome coincides with the virus transmission time order that SARS-CoV-2 starts in China, then outbreaks in Europe and finally in the USA.

CONCLUSION

The magnitude of nucleotide substitution distance of SARS-CoV-2 is closely related to the transmission time order of SARS-CoV-2. This outcome reveals that the nucleotide substitution distance of SARS-CoV-2 may be used to infer the origin of COVID-19.

摘要

背景

全球新冠病毒感染病例数已达1000万。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新冠病毒比严重急性呼吸综合征冠状病毒1(SARS-CoV-1)传染性更强。关于新冠病毒的起源存在争议。研究结果表明,全球所有SARS-CoV-2序列在2019年底有一个共同祖先。

方法

由于病毒随时间进化可能会出现更多突变,新冠病毒早期样本的病毒序列多样性应低于后期样本。病毒核苷酸序列的多样性可以通过核苷酸替代距离来衡量。为了探究SARS-CoV-2的多样性,我们使用不同的核苷酸替代模型来计算来自中国、欧洲和美国3个不同地区的SARS-CoV-2样本的距离。然后,我们利用这些距离来推断新冠病毒的起源。

结果

已知新冠病毒起源于中国武汉,然后传播到欧洲和美国。通过使用不同的替代模型,来自这些地区的SARS-CoV-2样本的距离存在显著差异。通过方差分析测试,p值小于2.2×10⁻¹⁶。大多数替代模型的分析结果表明,中国的多样性最低,其次是欧洲,最后是美国。这一结果与SARS-CoV-2先在中国出现,然后在欧洲爆发,最后在美国爆发的病毒传播时间顺序一致。

结论

SARS-CoV-2的核苷酸替代距离大小与SARS-CoV-2的传播时间顺序密切相关。这一结果表明,SARS-CoV-2的核苷酸替代距离可用于推断新冠病毒的起源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6f/7605616/fea7f8e488f4/IDR-13-3887-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6f/7605616/74946c3a0e77/IDR-13-3887-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6f/7605616/fea7f8e488f4/IDR-13-3887-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6f/7605616/74946c3a0e77/IDR-13-3887-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6f/7605616/fea7f8e488f4/IDR-13-3887-g0002.jpg

相似文献

1
Exploring Diversity of COVID‑19 Based on Substitution Distance.基于替换距离探索新冠病毒的多样性
Infect Drug Resist. 2020 Oct 29;13:3887-3894. doi: 10.2147/IDR.S277620. eCollection 2020.
2
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.西班牙的 SARS-CoV-2 早期传播归因于创始效应。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01583-20.
3
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
4
Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.COVID-19 病例的临床谱及其与 S.LDH 水平的相关性-来自拉贾斯坦邦东南部的观察性研究。
J Assoc Physicians India. 2021 Sep;69(9):11-12.
5
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
6
Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.基于刺突蛋白的进化动态和特定病毒突变对 SARS-CoV-2 全球传播的特征分析。
Infect Dis Poverty. 2021 Aug 21;10(1):112. doi: 10.1186/s40249-021-00895-4.
7
Temporal and Location Variations, and Link Categories for the Dissemination of COVID-19-Related Information on Twitter During the SARS-CoV-2 Outbreak in Europe: Infoveillance Study.欧洲SARS-CoV-2疫情期间推特上新冠疫情相关信息传播的时间和地点变化以及链接类别:信息监测研究
J Med Internet Res. 2020 Aug 28;22(8):e19629. doi: 10.2196/19629.
8
The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.新型冠状病毒(SARS-CoV-2)和 COVID-19 疫情。
Int Braz J Urol. 2020 Jul;46(suppl.1):6-18. doi: 10.1590/S1677-5538.IBJU.2020.S101.
9
The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.疫情初期防控措施下新型冠状病毒在中国的空间传播。
Arch Public Health. 2021 Jan 13;79(1):8. doi: 10.1186/s13690-021-00529-z.
10
[Analysis of Nucleotide Changes in RT-PCR Primer/Probe Binding Regions in SARS-CoV-2 Isolates Reported from Turkey].[土耳其报告的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)分离株逆转录聚合酶链反应(RT-PCR)引物/探针结合区域的核苷酸变化分析]
Mikrobiyol Bul. 2021 Jul;55(3):311-326. doi: 10.5578/mb.20219803.

引用本文的文献

1
Medical Benefits and Polymer Applications of Grapes.葡萄的医学益处及聚合物应用
Polymers (Basel). 2025 Mar 12;17(6):750. doi: 10.3390/polym17060750.
2
Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的德尔塔变异株和奥密克戎变异株在跨膜丝氨酸蛋白酶2(TMPRSS2)使用上的差异:对儿童病例突然增加的启示
PLoS One. 2024 Jun 13;19(6):e0299445. doi: 10.1371/journal.pone.0299445. eCollection 2024.
3
Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA.

本文引用的文献

1
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2.新冠病毒基因组多样性和反复出现的突变。
Infect Genet Evol. 2020 Sep;83:104351. doi: 10.1016/j.meegid.2020.104351. Epub 2020 May 5.
2
Genotyping coronavirus SARS-CoV-2: methods and implications.冠状病毒 SARS-CoV-2 的基因分型:方法与意义。
Genomics. 2020 Sep;112(5):3588-3596. doi: 10.1016/j.ygeno.2020.04.016. Epub 2020 Apr 27.
3
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
抗N-甲基-D-天冬氨酸受体脑炎、人乳头瘤病毒与微小核糖核酸
Curr Med Chem. 2025;32(4):771-787. doi: 10.2174/0109298673264615231124072130.
4
Beneficial medicinal effects and material applications of rose.玫瑰的有益药用功效及物质应用。
Heliyon. 2023 Dec 10;10(1):e23530. doi: 10.1016/j.heliyon.2023.e23530. eCollection 2024 Jan 15.
5
The Potential of Collagen Treatment for Comorbid Diseases.胶原蛋白治疗合并症的潜力。
Polymers (Basel). 2023 Oct 5;15(19):3999. doi: 10.3390/polym15193999.
6
COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA.新型冠状病毒肺炎、抗 N- 甲基-D-天冬氨酸受体脑炎与 microRNA
Front Immunol. 2022 Mar 22;13:825103. doi: 10.3389/fimmu.2022.825103. eCollection 2022.
7
A Review of the Effects of Collagen Treatment in Clinical Studies.胶原蛋白治疗在临床研究中的效果综述。
Polymers (Basel). 2021 Nov 9;13(22):3868. doi: 10.3390/polym13223868.
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
4
SARS-CoV-2 and COVID-19: The most important research questions.严重急性呼吸综合征冠状病毒2与冠状病毒病2019:最重要的研究问题。
Cell Biosci. 2020 Mar 16;10:40. doi: 10.1186/s13578-020-00404-4. eCollection 2020.
5
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
6
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).新型冠状病毒(2019-nCoV)感染的肺炎快速诊治指南(标准版)。
Mil Med Res. 2020 Feb 6;7(1):4. doi: 10.1186/s40779-020-0233-6.
7
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
8
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情,该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
9
Coronavirus infections and immune responses.冠状病毒感染与免疫应答。
J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.